Patent AT-E401338-T1: [Translated] CITRULLINE PEPTIDES DERIVED FROM FIBRIN RECOGNIZED BY AUTOANTIBODIES SPECIFIC TO RHEUMATOID ARTHRITIS AND THE USE THEREOF
Description
The invention relates to novel citrulline peptides derived from fibrin α and β chains which are recognizable by specific citrulline antiprotein autoantibodies (AAPC) of a rheumatoid arthritis (PR) and to the use thereof for detecting the presence of said specific PR AAPC in a biological sample.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the complete Patent AT-E401338-T1: [Translated] CITRULLINE PEPTIDES DERIVED FROM FIBRIN RECOGNIZED BY AUTOANTIBODIES SPECIFIC TO RHEUMATOID ARTHRITIS AND THE USE THEREOF on the official website. |
https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401338-T1 |
Tags
- patent
- chemistry
- research
- innovation
- pubchem